IDSA News - December 2011/January 2012  (Plain Text Version)

Return to Graphical Version

 

In this issue:
Patient Care and Science
•  Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
•  Help Boost ID Participation in Physician Compensation Survey
•  Webinar: Billing and Coding Update for 2012
•  Congress Should Repeal Flawed Physician Payment Formula
•  IDSA Comments on Medicare Conditions of Participation
Global ID
•  Early HIV Treatment Study Named Breakthrough of the Year
•  PEPFAR Takes Hit, Military HIV Research Program Survives
•  Level of HIV in Blood Major Factor in Sexual Transmission
•  “Totally” Drug Resistant TB in India
Policy and Advocacy
•  FDA Limits Cephalosporin Use in Food Animals
•  IDSA, PIDS, SHEA Urge Mandatory HCW Influenza Vaccination
•  Organ Transplant Guidelines Should Take Balanced Approach
•  IDSA Raises Alarm on Anti-Infective Drug Shortages
•  ID Funding Should Be Federal Budget Priority
Your Colleagues
•  Check Out “My IDSA” for Latest Member News
Education & Resources
•  Antimicrobial Resistance CME Activity Available Online
•  Discount for IDSA Members on OUP Books
Top Stories
•  From the President: IDSA Needs You, More Than Ever
•  NIAID Seeks Lead Investigators for Antibacterial Resistance Clinical Research Network
•  EIN Update: Cases of M. abscessus Continue to Pose Treatment Challenges
•  IDSA Journal Club

 

Drug Approvals, Recalls, Adverse Events Update

IDSA offers two email services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Content includes a range of topics, including new drug approvals and warnings. Recent alerts have included:

IDSA members can sign up for these services online. (You must be logged in to have access to this link. Once logged in, click on the “My Alerts” tab to subscribe to the alerts. To subscribe, check the appropriate boxes to receive CDC’s Health Alert Network (HAN) messages and/or alerts from FDA, and provide your email address and name where indicated.)

Is Your Facility Experiencing Antibiotic Shortages?

IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at schang@idsociety.org.